Free Trial

Best Stocks Under $10 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $10.00 (10 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Curaleaf stock logo

1. Curaleaf OTCMKTS:CURLF

$3.55 +0.14 (+4.18%)
As of 01:02 PM Eastern

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. More about Curaleaf

Market Capitalization
$2.48 billion
Consensus Rating
Strong Buy
Volume
573,479 shares
Average Volume
1.08 million shares
Today's Range
$3.33
$3.62
50-Day Range
$1.89
$3.99
Ur Energy stock logo

2. Ur Energy NYSEAMERICAN:URG

$1.96 +0.04 (+1.81%)
As of 01:22 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$780.75 million
Consensus Rating
Buy
Consensus Price Target
$2.57 (+30.6% Upside)
Volume
4.08 million shares
Average Volume
9.39 million shares
Today's Range
$1.88
$1.97
Marks and Spencer Group stock logo

3. Marks and Spencer Group OTCMKTS:MAKSY

$9.95 +0.14 (+1.39%)
As of 01:01 PM Eastern

Marks and Spencer Group plc operates various retail stores. It operates through five segments: UK Clothing & Home, UK Food, International, Ocado, and All Other. More about Marks and Spencer Group

Market Capitalization
$10.28 billion
Consensus Rating
Buy
Volume
50,981 shares
Average Volume
187,294 shares
Today's Range
$9.89
$9.98
50-Day Range
$8.36
$10.00
iBio stock logo

4. iBio NASDAQ:IBIO

$1.92 +0.08 (+4.40%)
As of 01:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBio

Market Capitalization
$95.63 million
Consensus Rating
Buy
Consensus Price Target
$4.75 (+147.3% Upside)
Volume
576,956 shares
Average Volume
1.38 million shares
Today's Range
$1.83
$2.00
Byrna Technologies stock logo

5. Byrna Technologies NASDAQ:BYRN

$6.15 +0.13 (+2.16%)
As of 01:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Byrna Technologies Inc, a non-lethal defense technology company, provides non-lethal alternative solutions for law enforcement and private security. More about Byrna Technologies

Market Capitalization
$139.50 million
P/E Ratio
17.08
Consensus Rating
Buy
Consensus Price Target
$12.13 (+97.2% Upside)
Volume
116,174 shares
Average Volume
531,256 shares
Inhibikase Therapeutics stock logo

6. Inhibikase Therapeutics NASDAQ:IKT

$1.70 +0.03 (+1.50%)
As of 01:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase Therapeutics

Market Capitalization
$223.79 million
Consensus Rating
Buy
Consensus Price Target
$5.50 (+224.5% Upside)
Volume
142,107 shares
Average Volume
1.41 million shares
Today's Range
$1.69
$1.73
Exodus Movement stock logo

7. Exodus Movement NYSEAMERICAN:EXOD

$6.59 -0.09 (-1.29%)
As of 01:20 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Exodus Movement, Inc develops blockchain asset investors platform to secure, exchange and manage wealth inside one application. More about Exodus Movement

Market Capitalization
$197.74 million
Consensus Rating
Buy
Consensus Price Target
$23.50 (+256.4% Upside)
Volume
41,580 shares
Average Volume
85,879 shares
Today's Range
$6.52
$6.90
Aclaris Therapeutics stock logo

8. Aclaris Therapeutics NASDAQ:ACRS

$4.58 +0.16 (+3.64%)
As of 01:22 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris Therapeutics

Market Capitalization
$644.53 million
Consensus Rating
Buy
Consensus Price Target
$11.50 (+151.0% Upside)
Volume
271,098 shares
Average Volume
1.93 million shares
Today's Range
$4.42
$4.63
Tele2 stock logo

9. Tele2 OTCMKTS:TLTZY

$9.24 -0.30 (-3.10%)
As of 01:01 PM Eastern

Tele2 AB (publ) provides fixed and mobile connectivity, handset related data services, and entertainment services in Sweden, Lithuania, Latvia, and Estonia. More about Tele2

Market Capitalization
$12.66 billion
P/E Ratio
11.84
Consensus Rating
Buy
Volume
34,678 shares
Average Volume
45,059 shares
Today's Range
$9.23
$9.42
Perspective Therapeutics stock logo

10. Perspective Therapeutics NYSEAMERICAN:CATX

$3.24 -0.32 (-9.10%)
As of 01:22 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization
$370.09 million
Consensus Rating
Buy
Consensus Price Target
$12.63 (+290.1% Upside)
Volume
2.28 million shares
Average Volume
2.57 million shares
Today's Range
$3.26
$3.63
Inventiva stock logo

11. Inventiva NASDAQ:IVA

$4.31 +0.27 (+6.71%)
As of 01:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. More about Inventiva

Market Capitalization
$893.98 million
Consensus Rating
Buy
Consensus Price Target
$16.56 (+284.0% Upside)
Volume
1.11 million shares
Average Volume
433,703 shares
Today's Range
$3.98
$4.49
Larimar Therapeutics stock logo

12. Larimar Therapeutics NASDAQ:LRMR

$3.16 -0.04 (-1.09%)
As of 01:22 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Larimar Therapeutics, Inc, a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. More about Larimar Therapeutics

Market Capitalization
$329.82 million
Consensus Rating
Buy
Consensus Price Target
$15.29 (+383.0% Upside)
Volume
773,680 shares
Average Volume
3.10 million shares
Today's Range
$3.16
$3.35
Novagold Resources stock logo

13. Novagold Resources NYSEAMERICAN:NG

$8.22 +0.17 (+2.05%)
As of 01:22 PM Eastern
This is a fair market value price provided by Massive. Learn more.

NovaGold Resources Inc explores for and develops gold mineral properties in the United States. Its principal asset is the Donlin Gold project consisting of 493 mining claims covering an area of approximately 29,008 hectares located in the Kuskokwim region of southwestern Alaska. More about Novagold Resources

Market Capitalization
$3.61 billion
Consensus Rating
Buy
Consensus Price Target
$13.26 (+61.4% Upside)
Volume
915,812 shares
Average Volume
3.66 million shares
Today's Range
$8.17
$8.45
Aquestive Therapeutics stock logo

14. Aquestive Therapeutics NASDAQ:AQST

$4.16 +0.13 (+3.10%)
As of 01:22 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Aquestive Therapeutics, Inc operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. More about Aquestive Therapeutics

Market Capitalization
$521.25 million
Consensus Rating
Buy
Consensus Price Target
$8.80 (+111.8% Upside)
Volume
1.36 million shares
Average Volume
3.35 million shares
Today's Range
$4.05
$4.22
StorageVault Canada stock logo

15. StorageVault Canada OTCMKTS:SVAUF

$3.09 0.00 (0.00%)
As of 06/2/2026

StorageVault Canada Inc owns, manages, and rents self-storage and portable storage space to individual and commercial customers in Canada. More about StorageVault Canada

Consensus Rating
Buy
Volume
14,402 shares
Average Volume
27,776 shares
Today's Range
$3.09
$3.09
50-Day Range
$3.00
$3.41
52-Week Range
$2.66
$3.78
Achieve Life Sciences stock logo

16. Achieve Life Sciences NASDAQ:ACHV

$5.31 +0.39 (+8.01%)
As of 01:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. More about Achieve Life Sciences

Market Capitalization
$550.26 million
Consensus Rating
Buy
Consensus Price Target
$14.67 (+176.0% Upside)
Volume
764,527 shares
Average Volume
1.03 million shares
Today's Range
$4.88
$5.50
Hensoldt stock logo

17. Hensoldt OTCMKTS:HAGHY

$9.02 -0.15 (-1.64%)
As of 12:34 PM Eastern

HENSOLDT AG, together with its subsidiaries, provides defense and security electronic sensor solutions worldwide. It offers air surveillance, airborne, ground based, security, naval and coastal, and space radars; identification friend or foe and secure data links; and commercial shipping solutions. More about Hensoldt

Market Capitalization
$10.42 billion
Consensus Rating
Buy
Volume
15,103 shares
Average Volume
134,138 shares
Today's Range
$8.97
$9.14
50-Day Range
$7.68
$10.46
Peraso stock logo

18. Peraso NASDAQ:PRSO

$1.08 +0.02 (+1.42%)
As of 01:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Peraso Inc, a fabless semiconductor company, develops, markets, and sells semiconductor devices and modules. The company's products include millimeter wavelength (mmWave) ICs, including baseband IC, various mmWave radio frequency, integrated circuits, as well as associated antenna technology; and mmWave antenna modules. More about Peraso

Market Capitalization
$15.85 million
Consensus Rating
Buy
Consensus Price Target
$3.00 (+179.1% Upside)
Volume
223,694 shares
Average Volume
5.34 million shares
Today's Range
$1.04
$1.09
Dream Industrial Real Estate Investment Trust stock logo

19. Dream Industrial Real Estate Investment Trust OTCMKTS:DREUF

$9.98 +0.05 (+0.50%)
As of 11:43 AM Eastern

Dream Industrial REIT is an unincorporated, open-ended real estate investment trust. As at December 31, 2023, we own, manage and operate a global portfolio of well-located, diversified industrial properties comprising 327 assets totalling approximately 71.4 million square feet of GLA in key markets across Canada, Europe and the U.S. More about Dream Industrial Real Estate Investment Trust

P/E Ratio
9.80
Consensus Rating
Buy
Volume
631 shares
Average Volume
46,288 shares
Today's Range
$9.98
$9.98
50-Day Range
$8.85
$10.42
Stereotaxis stock logo

20. Stereotaxis NYSEAMERICAN:STXS

$1.88 +0.04 (+2.23%)
As of 01:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about Stereotaxis

Market Capitalization
$185.71 million
Consensus Rating
Buy
Consensus Price Target
$3.88 (+106.0% Upside)
Volume
113,581 shares
Average Volume
462,376 shares
Today's Range
$1.85
$1.91
Citizens stock logo

21. Citizens NASDAQ:CIZN

$9.54 0.00 (0.00%)
As of 06/3/2026 03:45 PM Eastern

Citizens Holding Company operates as the bank holding company for The Citizens Bank of Philadelphia that provides various commercial and personal banking products and services. More about Citizens

Market Capitalization
$54.32 million
P/E Ratio
9.73
Consensus Rating
Buy
Consensus Price Target
$22.00 (+130.6% Upside)
Volume
688 shares
Average Volume
3,595 shares
Taysha Gene Therapies stock logo

22. Taysha Gene Therapies NASDAQ:TSHA

$5.74 +0.19 (+3.33%)
As of 01:22 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Taysha Gene Therapies, Inc, a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. More about Taysha Gene Therapies

Market Capitalization
$1.65 billion
Consensus Rating
Buy
Consensus Price Target
$11.64 (+102.9% Upside)
Volume
435,353 shares
Average Volume
2.64 million shares
Today's Range
$5.55
$5.84
Standard Lithium stock logo

23. Standard Lithium NYSEAMERICAN:SLI

$3.87 -0.06 (-1.53%)
As of 01:04 PM Eastern

Standard Lithium Ltd. explores for, develops, and processes lithium brine properties in the United States. Its flagship project is the Lanxess project with area of approximately 150,000 acres located in southern Arkansas. More about Standard Lithium

Market Capitalization
$942.96 million
Consensus Rating
Buy
Consensus Price Target
$5.13 (+32.4% Upside)
Volume
589,800 shares
Average Volume
2.24 million shares
Today's Range
$3.83
$3.91
LifeStance Health Group stock logo

24. LifeStance Health Group NASDAQ:LFST

$7.68 +0.19 (+2.47%)
As of 01:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. More about LifeStance Health Group

Market Capitalization
$2.98 billion
P/E Ratio
128.25
Consensus Rating
Buy
Consensus Price Target
$9.86 (+28.3% Upside)
Volume
655,718 shares
Average Volume
3.20 million shares
Global Net Lease stock logo

25. Global Net Lease NYSE:GNL

$9.28 +0.08 (+0.81%)
As of 01:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Global Net Lease, Inc (NYSE: GNL) is a publicly traded real estate investment trust listed on the NYSE. The firm focused on acquiring a diversified global portfolio of commercial properties, with an emphasis on sale-leaseback transactions involving single tenant, mission critical income producing net-leased assets across the United States, Western and Northern Europe.

Market Capitalization
$1.97 billion
Consensus Rating
Buy
Consensus Price Target
$10.40 (+12.0% Upside)
Volume
406,338 shares
Average Volume
1.93 million shares
Today's Range
$9.27
$9.35